AirJoule Technologies (NasdaqCM:AIRJ) Q4 2025 Earnings call March 31, 2026 08:30 AM ET Company ParticipantsAlex Fuhrman - Managing DirectorBryan Barton - CCOMatt Jore - CEOMichael Legg - Managing Director of Equity ResearchPat Eilers - Executive ChairmanStephen Pang - CFOTom Divine - VP of Investor Relations and FinanceNone - Company RepresentativeOperatorGreetings. Welcome to the AirJoule Technologies fourth quarter and full year 2025 earnings call. At this time, all participants are in listen-only mode. T ...

AirJoule Technologies (NasdaqCM:AIRJ) Q4 2025 Earnings call March 31, 2026 08:30 AM ET Speaker4Greetings. Welcome to the AirJoule Technologies fourth quarter and full year 2025 earnings call. At this time, all participants are in listen-only mode. The question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. Please note this conference is being recorded. It is now my pleasure to turn t ...

TM AirJoule Technologies Corporation (Nasdaq: AIRJ) Q4 and FY 2025 Earnings Presentation March 31, 2026 https://airjouletech.com DISCLAIMERS Forward Looking Statements The information in this presentation includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of present or historical fact included in this presentation, regarding AirJoule Techno ...

Group 1 - Xylem will ring the closing bell at the NYSE to celebrate World Water Day 2026 and its clean water initiatives [3][4] - Edison Electric Institute is celebrating 250 years of American innovation, with its President and CEO Drew Maloney participating in a discussion on NYSE Live [4] - The NYSE provides daily pre-market updates, highlighting market insights and trading activities [1][4] Group 2 - The S&P 500 index decreased by 1.4% on Wednesday, while the Dow Jones Industrial Average reached a new low for 2026, influenced by rising oil prices and the ongoing conflict in Iran [4]

Core Insights - Nephros, Inc. reported a 33% year-over-year increase in full-year net revenue, reaching $18.8 million, and a 22% increase in fourth-quarter net revenue to $4.7 million, marking the highest quarterly revenue in the company's history [1][4][3] - The company achieved positive net income for the second consecutive year, with a net income of $1.2 million for the full year and $62,000 for the fourth quarter [1][10] Financial Performance - Full-year net revenue for 2025 was $18.8 million, up from $14.2 million in 2024, representing a 33% increase [4] - Fourth-quarter net revenue was $4.7 million, compared to $3.9 million in the same quarter of 2024, an increase of 22% [4] - Net income for the year was $1.2 million, compared to $74,000 in 2024, while fourth-quarter net income was $62,000, down from $349,000 in the previous year [10] - Adjusted EBITDA for the year was $1.6 million, compared to $548,000 in 2024, while for the fourth quarter, it was approximately $131,000, down from $481,000 in the same period of 2024 [11] Cost and Expenses - Cost of goods sold for the year was $7.2 million, up from $5.4 million in 2024, a 32% increase, while for the fourth quarter, it was $2 million, compared to $1.4 million in the same quarter of 2024, a 41% increase [5] - Selling, general, and administrative expenses for the year were $9 million, up from $7.7 million in 2024, a 17% increase, and for the fourth quarter, these expenses were approximately $2.3 million, compared to $1.9 million in 2024, a 24% increase [7] - Research and development expenses for the year were $1.3 million, compared to $0.9 million in 2024, and for the fourth quarter, they were $0.4 million, up from $0.3 million in the same period of 2024, a 57% increase [8] Strategic Developments - The company has focused on three growth pillars: Products, Service, and Education, which have driven revenue gains [3] - Nephros expanded its service offerings and launched the Nephros Water Institute to enhance its authority in waterborne pathogen mitigation and facility water safety [3] - The company extended its long-term supply agreement with Medica, ensuring continuity of supply and supporting sustained growth [3]

Core Insights - Nephros, Inc. reported a significant increase in net revenue, achieving $18.8 million for the fiscal year 2025, a 33% increase year-over-year, and $4.7 million for the fourth quarter, up 22% year-over-year [1][5][7] - The company has achieved positive net income for the second consecutive year, with net income of $1.2 million for the year and $62,000 for the fourth quarter [12][7] Financial Performance - For the fiscal year ended December 31, 2025, net revenue was $18.8 million compared to $14.2 million in 2024, marking a 33% increase [5][7] - Fourth-quarter net revenue was $4.7 million, up from $3.9 million in the same quarter of 2024, representing a 22% increase [5][7] - The increase in revenue was driven by higher programmatic revenue, strong reorder activity, and growth in the emergency response business [5][7] Cost and Expenses - Cost of goods sold for the year was $7.2 million, an increase of 32% from $5.4 million in 2024 [6] - Selling, general, and administrative expenses rose to $9 million for the year, a 17% increase from $7.7 million in 2024, primarily due to higher bonuses and sales commissions [9] - Research and development expenses increased to $1.3 million for the year, up from $0.9 million in 2024, reflecting a 57% increase in the fourth quarter [10] Profitability Metrics - Gross margin for the year remained stable at 62%, while the fourth-quarter gross margin decreased to 58% from 64% in the previous year [6][7] - Adjusted EBITDA for the year was $1.6 million, compared to $0.5 million in 2024, while fourth-quarter adjusted EBITDA was approximately $131,000, down from $481,000 in the same quarter of 2024 [13][7] Strategic Developments - The company has focused on three growth pillars: Products, Service, and Education, which have contributed to its revenue growth [4] - Nephros launched the Nephros Water Institute to enhance its authority in waterborne pathogen mitigation and facility water safety, aiming to strengthen customer engagement and long-term demand [4] Cash Position - As of December 31, 2025, Nephros had cash and cash equivalents of approximately $5.4 million, an increase from $3.8 million at the end of 2024 [13]

Core Insights - Xylem Inc. (XYL) is a global water technology company with a market cap of $29.8 billion, focusing on engineered products and solutions for water and wastewater systems [1] - The company operates through four segments: Water Infrastructure, Applied Water, Measurement and Control Solutions, and Water Solutions and Services, catering to utility, industrial, and residential markets [1] Company Performance - XYL's shares have decreased 20.8% from its 52-week high of $154.27 and have declined 11.4% over the past three months, underperforming the Nasdaq Composite's 4.1% drop [3] - Year-to-date, XYL stock is down 9.9%, lagging behind the Nasdaq's 2.3% dip, and has fallen 4.3% over the past 52 weeks compared to the Nasdaq's 29.9% return [6] - The stock has been trading below its 50-day moving average since mid-November 2025 and below its 200-day moving average since early February [6] Financial Outlook - On February 10, XYL's stock tumbled over 8% after the company issued a cautious 2026 outlook, projecting revenue of $9.1 billion to $9.2 billion, which is below analyst consensus [7] - The forecast for adjusted EPS is $5.35 to $5.60, slightly below expectations of $5.55, with only 2% to 4% expected organic revenue growth for 2026 [7] Competitive Position - XYL has underperformed compared to its rival, Ingersoll Rand Inc. (IR), which has gained 8.9% year-to-date and 4% over the past 52 weeks [8] - Despite the underperformance, analysts maintain a moderately optimistic outlook for XYL, with a consensus rating of "Moderate Buy" and a mean price target of $158.38, suggesting a nearly 30% premium to current levels [8]

Core Insights - BluMetric Environmental Inc. has secured a US$1.5 million (CA$2.0 million) contract for a Membrane Bioreactor Wastewater Treatment Plant for a private housing development in Florida, capable of treating 150,000 gallons per day with an option to expand to 300,000 gallons per day [1][2] Group 1: Company Developments - The wastewater treatment segment is increasingly significant for BluMetric's WaterTech business, with the CEO highlighting the economic performance and reliability of their MBR technology [2] - The system will be manufactured by the WaterTech USA division in Gainesville, Florida, and is expected to be delivered and commissioned within the next twelve months [2] - BluMetric is in discussions to potentially double its manufacturing footprint from 25,000 square feet to 50,000 square feet in Gainesville to meet rising demand for U.S.-based projects [3] Group 2: Company Overview - BluMetric Environmental Inc. is a publicly traded firm specializing in water technology and environmental engineering, with over 335 employees across 16 offices and 3 manufacturing facilities [4] - The company has a history of over 50 years and serves various sectors including Commercial and Industrial, Government, Military, and Mining clients in North America and the Caribbean [4]

Core Viewpoint - Nephros, Inc. will announce its fourth-quarter financial results on March 12, 2026, and will host a conference call to discuss these results the same day at 4:30 PM ET [1]. Company Information - Nephros is a water technology company focused on providing filtration solutions for medical and commercial markets, emphasizing an integrated approach to water safety and quality [3]. - The company aims to enhance the human relationship with water through innovative filtration products and services, as well as water-quality education [3]. Conference Call Details - Participants can join the conference call via domestic access at 1 (844) 808-7106 and international access at 1 (412) 317-5285 [2]. - An audio archive of the call will be available shortly after the event on the Nephros Investor Relations page, with a replay accessible until March 19, 2026 [2].

Core Viewpoint - Nephros, Inc. will announce its fourth-quarter financial results on March 12, 2026, after market close, and will host a conference call at 4:30 PM ET on the same day [1]. Group 1: Financial Results Announcement - The fourth-quarter financial results will be filed on March 12, 2026, after market close [1]. - A conference call will take place on the same day at 4:30 PM ET for discussing the results [1]. - Participants can join the call using domestic access at 1 (844) 808-7106 or international access at 1 (412) 317-5285 [1]. Group 2: Call Replay Information - An audio archive of the call will be available shortly after the call on the Nephros Investor Relations page [2]. - A replay of the call can be accessed until March 19, 2026, using the number 1 (855) 669-9658 for domestic callers and 1 (412) 317-0088 for international callers, with the replay access code: 3018234 [2]. Group 3: Company Overview - Nephros is focused on improving the human relationship with water through accessible technology [2]. - The company provides innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety [2]. - Nephros serves customers in both medical and commercial markets, offering proactive and emergency solutions for water management [2].